Tools for Practice Outils pour la pratique

#156 The louse is (no longer) in the house

What is the best treatment for head lice?

Dimeticone (or dimethicone) appears superior to traditional lice treatments (like permethrin or malathion), getting one more in 3-4 patients lice free with no increased adverse events.  Dimeticone is a silicone-based product that suffocates lice and is applied to dry hair, left eight hours, and often repeated after one week 

CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session

Statistically significant results: 
  • Dimeticone versus permethrinTwo Randomized Controlled Trials (RCTs): 
    • British RCT of 90 patients (age 2-45),1 4% dimeticone once or 1% permethrin twice (one week  apart), found:   
      • More dimeticone patients lice free at day nine: 80% versus 36%, Number Needed to Treat (NNT)=3. 
      • Adverse events similar and none serious. 
    • Brazilian RCT of 145 children (age 5-15),2 two applications (one week apart) of 92% dimeticone or 1% permethrin found:  
      • More dimeticone patients lice free at day nine: 97% versus 68%, NNT=4. 
      • Adverse events: Two cases of ocular irritation from dimeticone.  
  • Dimeticone versus malathion: One British RCT of 73 patients (age 1-48),3 two applications (one week apart) of 4% dimeticone or 0.5% malathion. Analysis (considering drop-outs to have lice) found: 
    • More dimeticone patients lice free at day nine: 70% versus 33%, NNT=3. 
  • Other European dimeticone RCTs found cure rates of 83-92%4 and 70% in patients predominantly with longstanding lice and previous failed treatments.5 
  • 99% of North American lice express genes associated with traditional pediculicide resistance.6 
  • Dimeticone is a silicone-based product that acts as an occlusive to suffocate lice.7 
    • Other occlusive agents like isopropyl myristrate also appear more effective than traditional pediculicides.8  
  • In one study <20% children with nits developed active lice.9  
    • Wet combing better than visual inspection for diagnosing lice.10   
  • Head lice primarily transmitted from head to head contact in play, sharing beds, and occasionally by sharing objects like hats, combs.11 
    • To decrease re-infestation: Wash clothes worn and linens used two days prior in hot water and dry with high heat. Put un-washable items in a sealed bag for two weeks.12,13 
  • Lice treatments: Cost ~$30 most covered by drug plans.14 

DIANE ROTHON January 8, 2024

Very good article. Clear. Practical.

gregory Stroh April 29, 2024

Great article

Latest Tools for Practice
Derniers outils pour la pratique

#367 Oral Calcitonin Gene-related Peptide Antagonists: A painfully long name for the acute treatment of migraines

What are the risks and benefits of ubrogepant for the acute treatment of episodic migraines?
Read Lire 0.25 credits available Crédits disponibles

#366 Looking for Closure: Managing simple excisions or wounds efficiently

What are some options for efficiency in wound closure?
Read Lire 0.25 credits available Crédits disponibles

#365 Shrooms for Glooms: Evidence for psilocybin for depression

What are the benefits and harms of psilocybin for treatment-resistant/recurrent depression?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session

  • Michael Pierse MD FRCPC
  • Michael R Kolber BSc MD CCFP MSc
  • Tony Nickonchuk BScPharm

1. Burgess IF, Brunton ER, Burgess NA. BMC Dermatology. 2013; 13:5.

2. Heukelbach J, Pilger D, Oliveira FA, et al. BMC Infectious Diseases. 2008; 8:115.

3. Burgess IF, Lee PN, Matlock G. PLoS ONE. 2007; 2(11): e1127.

4. Kurt, O, Balcıoğlu IC, Burgess IF, et al. BMC Public Health. 2009; 9:441.

5. Burgess IF, Brown CM, Lee PN. BMJ. 2005; 330(7505):1423.

6. Yoon KP, Previte DJ, Hodgon HE, et al. J Med Entomol. 2014; 51:450-7.

7. G. Pohl-Boskamp GmbH & Co. KG. Product Monograph NYDA Dimeticone 100 cSt Solution, 50% w/w. September 11, 2012.

8. Burgess I. Clinical Evidence. 2011; 05:1703.

9. Williams LK, Reichert A, MacKenzie WR, et al. Pediatrics. 2001; 107:1011-5.

10. Jahnke C, Bauer E, Hengge ER, et al. Arch Dermatol. 2009; 145:309-13.

11. Devore CD, Schutze GE and The Council on School Health and Committee on Infectious Diseases. Pediatrics. 2015; 135;e1355-65.

12. Speare R, Cahill C, Thomas G. Int J Dermatol. 2003; 42:626-9.

13. Anonymous. Center for Disease Control and Prevention. Last updated December 28, 2015 available at: Last accessed January 13, 2016.

14. Nickonchuk T, Lee J, Allan GM, et al. Comparison of Commonly Prescribed Pharmaceuticals, Alberta 2016 (in press).

Authors do not have any conflicts to disclose.